Recent News

UNC Lineberger receives $4 million gift to support promising new cancer treatment

UNC Lineberger receives $4 million gift to support promising new cancer treatment

Seeking to help in the development of treatments for metastatic cancer, Alice Lehman of Charlotte has donated $4 million to further the work of UNC Lineberger's new cellular immunotherapy research program.

UNC Lineberger receives $4 million gift to support promising new cancer treatment - Read More…

Cancer burden for aging U.S. HIV population projected to shift

Cancer burden for aging U.S. HIV population projected to shift

UNC-Chapel Hill researcher Jessica Y. Islam, in collaboration with the National Cancer Institute and Centers for Disease Control and Prevention, reported findings Wednesday at the American Association for Cancer Research Annual Meeting that the total number of HIV-positive cancer patients in the United States is projected to decrease through 2030. She and her collaborators also projected that there would be a decrease in cancers linked to the advanced stage of HIV infection -- AIDS.

Cancer burden for aging U.S. HIV population projected to shift - Read More…

UNC Lineberger researchers speak at governor's mansion for launch of Metastatic Breast Cancer Awareness Month

UNC Lineberger researchers speak at governor's mansion for launch of Metastatic Breast Cancer Awareness Month

N.C. Gov. Roy Cooper declared April as Metastatic Breast Cancer Awareness Month in North Carolina to bring attention to this second-leading cause of cancer death among women. UNC Lineberger researchers joined First Lady Kristin Cooper at the Executive Mansion on Monday at a luncheon hosted by the North Carolina Oncology Navigator Association.

UNC Lineberger researchers speak at governor's mansion for launch of Metastatic Breast Cancer Awareness Month - Read More…

Nanoparticle treatment could improve immunotherapy against cancer

Nanoparticle treatment could improve immunotherapy against cancer

UNC Lineberger's Andrew Wang, MD, presented preliminary findings at the American Association for Cancer Research Annual Meeting 2017 from a preclinical study into the use of nanoparticles to improve the efficacy of immunotherapy drugs known as checkpoint inhibitors.

Nanoparticle treatment could improve immunotherapy against cancer - Read More…